Export

Bevacizumab
Essential medicine status
General description
Bevacizumab is a monoclonal antibody that binds to vascular endothelial growth factor (VEGF) and inhibits angiogenesis. It is used in the treatment of vascular eye diseases and in treatment protocols for some cancers.
INN
Bevacizumab
Medicine type
Biological agent
EML status history
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Ophthalmological preparations > Anti-vascular endothelial growth factor (VEGF) preparations
  • Parenteral > Locoregional injections > Intravitreal: 25 mg per mL